 (PIRS) Stock, Quote.Headers.trade-ideas

Pieris Pharmaceuticals

Crude-oil-4-logo

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AZTR

NUWE

PIRS

SGMO

Crude Oil Gains 1%; AT&amp;T Shares Rise After Q2 Earnings

xr:d:DAFhS-kD63I:2,j:45998648077,t:23042711

Movers

ALGM

ALKS

ALLR

ATCH

ATPC

BBLG

BLCO

CJET

CONN

CREV

DRMA

ENPH

FLEX

GERN

GOOGL

KARO

KORE

LITM

MANH

NAAS

NIVF

NUZE

Next Technology Holding Inc. - Ordinary Shares

NXTT

ROKU

SAGE

SLNA

SOAR

SYNX

TKNO

TSLA

ULTA

VSTM

Vintage Wine Estates, Inc. - Common Stock

WFRD

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Wall Street ai6

Earnings

Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results

<p>Financial giants have made a conspicuous bullish move on Freeport-McMoRan. Our analysis of options history for Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) revealed 11 unusual trades.</p>
<p>Delving into the details, we found 54% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $213,113, and 7 were calls, valued at $287,434.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $42.0 for Freeport-McMoRan over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Freeport-McMoRan's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Freeport-McMoRan's substantial trades, within a strike price spectrum from $30.0 to $42.0 over the preceding 30 days.</p>
<h3>Freeport-McMoRan Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245040_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$0.62</td>
<td>$0.59</td>
<td>$0.61</td>
<td>$30.00</td>
<td>$73.2K</td>
<td>68</td>
<td>1.3K</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.34</td>
<td>$0.31</td>
<td>$0.34</td>
<td>$42.00</td>
<td>$68.0K</td>
<td>7.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.95</td>
<td>$3.85</td>
<td>$3.9</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>1.2K</td>
<td>259</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.68</td>
<td>$2.66</td>
<td>$2.66</td>
<td>$40.00</td>
<td>$50.2K</td>
<td>4.3K</td>
<td>189</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.3</td>
<td>$5.25</td>
<td>$5.29</td>
<td>$42.00</td>
<td>$50.2K</td>
<td>7.4K</td>
<td>96</td>
</tr>
</tbody>
</table>
</p>
<h3>About Freeport-McMoRan</h3>
<p>Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. we expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.</p>
<h3>Where Is Freeport-McMoRan Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,177,817, with FCX's price down by -0.25%, positioned at $39.12.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 27 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Freeport-McMoRan options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Freeport-McMoRan Unusual Options Activity For December 26

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>CME Gr</strong>.</p>
<p>Looking at options history for CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) we detected 21 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 19% with bearish.</p>
<p>From the overall spotted trades, 11 are puts, for a total amount of $2,422,975 and 10, calls, for a total amount of $602,430.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $300.0 for CME Gr over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for CME Gr's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CME Gr's whale activity within a strike price range from $85.0 to $300.0 in the last 30 days. </p>
<h3>CME Gr Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245035_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$68.4</td>
<td>$65.0</td>
<td>$66.5</td>
<td>$300.00</td>
<td>$1.9M</td>
<td align="right">0</td>
<td align="right">300</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$154.1</td>
<td>$152.5</td>
<td>$154.1</td>
<td>$85.00</td>
<td>$154.1K</td>
<td align="right">5</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.8</td>
<td>$16.4</td>
<td>$16.55</td>
<td>$250.00</td>
<td>$87.7K</td>
<td align="right">7</td>
<td align="right">81</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$139.1</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$140.3</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">25</td>
</tr>
</tbody>
</table>
</p>
<h3>About CME Gr</h3>
<p>Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.</p>
<p>Having examined the options trading patterns of CME Gr, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is CME Gr Standing Right Now?</h3>
<ul>
<li>With a volume of 514,277, the price of CME is down -0.14% at $239.13. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for CME Gr</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $258.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on CME Gr, maintaining a target price of $257.<br />
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Market Perform rating on CME Gr, maintaining a target price of $260. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CME Gr, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About CME Gr

<p>Financial giants have made a conspicuous bearish move on Chevron. Our analysis of options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 20% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $173,100, and 7 were calls, valued at $362,356.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $170.0 for Chevron over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Chevron's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chevron's whale trades within a strike price range from $75.0 to $170.0 in the last 30 days. </p>
<h3>Chevron Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245029_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.99</td>
<td>$2.87</td>
<td>$2.99</td>
<td>$145.00</td>
<td>$119.6K</td>
<td>9.1K</td>
<td align="right">434</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.25</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$170.00</td>
<td>$93.0K</td>
<td>640</td>
<td align="right">229</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$70.4</td>
<td>$68.55</td>
<td>$69.43</td>
<td>$75.00</td>
<td>$69.4K</td>
<td>21</td>
<td align="right">12</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$45.4</td>
<td>$44.05</td>
<td>$44.64</td>
<td>$100.00</td>
<td>$53.5K</td>
<td>20</td>
<td align="right">12</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$15.6</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$130.00</td>
<td>$47.7K</td>
<td>8</td>
<td align="right">45</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chevron</h3>
<p>Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.</p>
<p>In light of the recent options history for Chevron, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Chevron</h3>
<ul>
<li>With a volume of 2,747,664, the price of CVX is down -0.21% at $143.54. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>What The Experts Say On Chevron</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $179.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Chevron, targeting a price of $188.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on Chevron, which currently sits at a price target of $160.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Chevron, targeting a price of $195.<br />
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $173. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chevron options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Chevron

<p>There&#8217;s something magical about moving into a newly constructed home: the smell of recently milled wood, new paint and gleaming tiles – knowing no one has lived there before you. However, like anything in real estate, that privilege comes with a price. According to a recent report from <a href="https://www.benzinga.com/real-estate/24/11/42234719/redfin-reveals-22-of-renters-say-they-have-nothing-left-after-paying-rent">Redfin</a>, asking rents for newly constructed apartments rose 1.5% – the biggest year-over-year increase in 18 months – to a median of $1,802 in the third quarter.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"><strong> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</strong></a></strong></li>
<li><strong>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf"><strong>7-9% target yield with monthly dividends would you invest in it</strong></a>?</strong></li>
</ul>
<p>It&#8217;s a surprising stat given that the deluge of newly constructed apartments, primarily in Sunbelt states, caused rents for new apartments to fall by more than 7% in Q1 and Q2. The latest numbers reflect that the newer apartments are now being filled. Redfin based its numbers on an analysis of the U.S. Census Bureau&#8217;s data for newly constructed, unfurnished, unsubsidized, privately financed rental apartments in buildings with five or more units. Apartments completed in the second quarter of 2024 and either rented or not rented within three months were used to compile the survey.</p>
<h2 class="wp-block-heading">The Northeast Stumbles While Everywhere Else Soars</h2>
<p>Only the Northeast saw asking rents fall (-3.6%) after the number of recently finished apartments rose 13% year over year in the second quarter to the highest level since the fourth quarter of 2022. The rental decrease could have been due to several reasons – primarily that rents in the Northeast, particularly in places like Boston and <a href="https://www.benzinga.com/real-estate/24/12/42256888/as-nyc-rents-hit-new-highs-85-of-residents-look-to-buy-elsewhere-heres-what-they-find">New York</a>, were already high, with many residents moving to the Sunbelt states, according to government census data.&nbsp;</p>
<p><strong>See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks-y2"><strong>this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</strong></a></strong></p>
<p>&#8220;We would usually predict that rents will stay flat or even potentially fall when there are so many new apartment buildings opening up. What&#8217;s interesting in the third quarter is that rents are rising by more than the national average in the West and Midwest, even after the number of new apartments spiked between 30-50%,&#8221; Redfin Senior Economist Sheharyar Bokhari said in the report. &#8220;This is likely due to more new apartments being built in more expensive metros in each region, pushing the overall levels up.&#8221;</p>
<h2 class="wp-block-heading">High-End Finishes and Amenities</h2>
<p>The competition among new multifamily developments for tenants has led to higher-end finishes and more amenities, even among mid-priced rentals. Comfort, sustainability and catering to the increased number of work-from-home or hybrid working tenants have been at the forefront of developers&#8217; minds.</p>
<p><strong>Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"><strong> you can become an investor for $0.80 per share today.</strong></a></strong></p>
<p>&#8220;From state-of-the-art fitness facilities to luxurious pools, <a href="https://www.benzinga.com/markets/24/08/40168219/despite-market-challenges-multifamily-real-estate-shines-50-of-our-loans-this-year-says-industry-exp">multifamily developments</a> can bring a unique experience to day-to-day life,&#8221; Jared Bradley, president and founder of The Bradley Projects, told<a href="https://www.multifamilyexecutive.com/design-development/design/10-top-multifamily-design-trends-for-2024_o"> </a>multifamilyexecutive.com. &#8220;Small pockets of privacy for tenants to complete their work gives residents the feeling of &#8216;leaving their apartment&#8217; without stepping outside the building,&#8221; he added. &#8220;The confines of apartments can sometimes feel tight for working from home and areas designated for remote workers can allow tenants to leave their units and work from other comfortable places in their building.&#8221;</p>
<h2 class="wp-block-heading">More Of The Same In 2025</h2>
<p>According to<a href="https://www.yardimatrix.com/publications/download/file/6638-MatrixMultifamilyNationalReport-Winter2025?signup=false"> </a>a new outlook from Yardi Matrix, rents for new developments will continue to grow in 2025, outstripping other sectors of the multifamily sector. The report stated that a &#8220;large number of properties under construction will support robust supply growth again in 2025 … which will push rents higher as the supply boom starts to fade.&#8221;</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>The<a href="https://www.benzinga.com/go/equitymultiple-yf"><strong> Ascent Income Fund</strong></a> from EquityMultiple targets stable income from senior commercial real estate debt positions and has a historical distribution yield of 12.1% backed by real assets.<a href="https://www.benzinga.com/go/equitymultiple-yf"><strong> Earn a 1% return boost on your first EquityMultiple investment when you sign up here (accredited investors only)</strong></a>.</strong></li>
<li><strong>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100"><strong>become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</strong></a></strong></li>
</ul>


Dreaming Of Moving Into A Newly Constructed Apartment? Redfin Reports The Shocking Premium For That Privilege As Rents Soar

<p><strong>Palladyne AI Corp. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares are trading higher on possible continued momentum Thursday. The company announced that it completed the first autonomous tracking flight using its <a href="https://www.benzinga.com/pressreleases/24/12/b42647049/palladyne-ai-achieves-key-milestone-with-first-small-drone-autonomous-tracking-flight">Palladyne Pilot AI software platform</a> on Monday.</p>
<p><strong>What To Know: </strong>The test involved a third-party small drone that identified, prioritized and autonomously tracked terrestrial targets. This marked the first time Palladyne's AI platform interfaced with third-party autopilot software, enabling the drone to autonomously navigate while following a target.</p>
<p>Previously, the AI system demonstrated target identification and prioritization on stationary nodes and hovering drones. This new test flight expands the platform&#8217;s capabilities and moves it closer to commercialization, expected by the end of first-quarter 2025.</p>
<p>&#8220;Once we complete commercialization of Palladyne Pilot &#8212; which we expect to happen by the end of the&nbsp;first quarter&nbsp;of 2025 &#8212; small, economical drones will finally offer some of the same intelligence capabilities that larger, multi-million-dollar unmanned systems have had for years,&#8221; said <strong>Dr. Denis Garagic</strong>, co-founder and CTO, Palladyne AI.</p>
<p><strong>PDYN Price Action:</strong> Palladyne shares were up 44.7% at $7.15 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="513" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1024x513.png" alt="" class="wp-image-707848" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1024x513.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-768x385.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1536x770.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32.png 1912w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42687003/kemper-to-rally-more-than-25-here-are-4-top-analyst-forecasts-for-thursday">Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday</a></strong></li>
</ul>
<p><em>Image Via Shutterstock.</em></p>


PDYN

Palladyne AI Shares Are Surging Today: What you Need To know

<p><strong>AMC Entertainment Holdings Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) stock is spinning its wheels on Thursday despite a strong move in shares of retail darling <strong>GameStop Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>). The two often trade in sympathy, but the retail crowd may have found shinier toys <a href="https://www.benzinga.com/topic/holiday-sales">this holiday season</a>.</p>
<p><strong>What To Know:</strong> Meme stock trader&nbsp;<strong>Keith Gill</strong>,&nbsp;also known as&nbsp;<a href="https://www.benzinga.com/topic/roaring-kitty" target="_blank" rel="noreferrer noopener">&#8220;Roaring Kitty,&#8221;</a>&nbsp;posted an <a href="https://x.com/TheRoaringKitty/status/1871933930963693706">image</a> of a wrapped gift in traditional Christmas colors Wednesday while markets were closed for the holiday. </p>
<p>GameStop shares were up more than 5% at last check on the heels of the Roaring Kitty post, per <a href="http://pro.benzinga.com">Benzinga Pro</a>. </p>
<p>Other so-called meme stocks were also getting a lift, including <strong>Koss Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) and <strong>BlackBerry Ltd</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>). But AMC was trading flat to down after jumping briefly at the open. </p>
<p>AMC is considered one of the original meme stocks alongside GameStop. The stock has maintained cult-like support from a group of retail traders who call themselves apes since the meme stock craze of 2021. </p>
<p>AMC CEO <strong>Adam Aron</strong> has leaned into the support from retail traders. He <a href="https://x.com/CEOAdam/status/1871919103780548802">reposted</a> multiple X posts on Wednesday featuring images of apes watching movies at AMC theaters. </p>
<p><strong>Check This Out: <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42679610/roaring-kittys-christmas-post-has-gamestop-rallying-7-in-overnight-trading-memecoin-connected-to-trader-also-surge">Roaring Kitty&#8217;s &#8216;Christmas&#8217; Post Has GameStop Rallying 7% In Overnight Trading — Memecoin Connected To Trader Also Surge</a></strong></p>
<p><strong>Imax Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) CEO <strong>Rich Gelfond</strong> also provided strong commentary on recent box office strength in an interview on CNBC&#8217;s &#8220;Squawk On The Street&#8221; Thursday morning. </p>
<p>&#8220;The great thing about this time of year is every day is like a weekend &#8230; so a lot of momentum at the end of the year,&#8221; Gelfond said.</p>
<p>He noted that box office demand has been &#8220;really terrific&#8221; since Thanksgiving and suggested that a lot of families were visiting theaters on Christmas Eve and Christmas Day.</p>
<p>All of this seems to bode well for AMC, yet the stock is struggling to gain any momentum on Thursday. Instead, traders appear to guess Roaring Kitty&#8217;s next move.</p>
<p>Gill took a position in <strong>Chewy Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) stock earlier this year and telegraphed the move by posting a picture of a dog on X before disclosing a 6.6% stake in the pet retailer a few days later. He <a href="https://www.benzinga.com/news/24/10/41614177/roaring-kitty-puts-chewy-stock-in-the-litter-box-gamestop-shares-move-higher-after-hours">dumped</a> his entire position in September.</p>
<p>Meme stocks began heating up again in early December after Gill&nbsp;<a href="https://www.benzinga.com/general/social-media/24/12/42349100/gamestop-rockets-as-roaring-kitty-returns-to-x-what-does-his-tweet-signal-ahead-of-q3-earnings" target="_blank" rel="noreferrer noopener">posted an image</a>&nbsp;of a TIME magazine cover featuring a blank computer screen and a video player paused at the 1:09 mark of a 4:20-long video. His only other post since is the image of a present posted on Wednesday. </p>
<p>There is a lot of speculation about what Roaring Kitty could be planning. One of the most popular guesses across Reddit&#8217;s r/WallStreetBets and Stocktwits appears to be a bet on <strong>Tilray Brands Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>). Tilray fits into the <a href="https://www.benzinga.com/topic/420">420 theme</a> and is due to report earnings before the market opens on Jan. 9, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Tilray was up about 4% at last check.</p>
<p>GameStop shares are up about 5% over the past month and are up more than 46% over the past three months. AMC shares, on the other hand, are down about 18% over the past month and are down about 8% over a three-month period.</p>
<p><strong>AMC Price Action:</strong> AMC shares were down 0.37% at $4.05 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42437928/after-another-cryptic-post-lets-remember-how-roaring-kitty-managed-to-surpass-even-nancy-pelosis-enormous-wealth"><strong>After Another Cryptic Post, Let&#8217;s Remember How Roaring Kitty Managed To Surpass Even Nancy Pelosi&#8217;s Enormous Wealth</strong></a></li>
</ul>
<p><em>Photo: Shutterstock.</em></p>


CHWY

IMAX

KOSS

TLRY

What's Going On With AMC Entertainment Stock?

<p>SMR Alliance example of nuclear power development in EU</p>
<p>Government officials say funding available for nuclear energy</p>
<p><a href="https://www.spglobal.com/commodity-insights/en/news-research/latest-news/electric-power/122624-eu-moving-to-develop-infrastructure-for-nuclear-energy-expansion-officials" title="https://www.spglobal.com/commodity-insights/en/news-research/latest-news/electric-power/122624-eu-moving-to-develop-infrastructure-for-nuclear-energy-expansion-officials">https://www.spglobal.com/commodity-insights/en/news-research/latest-news/electric-power/122624-eu-moving-to-develop-infrastructure-for-nuclear-energy-expansion-officials</a></p>


Macro Notification

General

'EU moving to develop infrastructure for nuclear energy expansion: officials' - S&P Global

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Booking Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BKNG, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 35 uncommon options trades for Booking Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 31% bullish and 40%, bearish.</p>
<p>Out of all of the special options we uncovered, 9 are puts, for a total amount of $257,415, and 26 are calls, for a total amount of $1,886,689.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $4000.0 to $6500.0 for Booking Holdings over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Booking Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Booking Holdings's whale trades within a strike price range from $4000.0 to $6500.0 in the last 30 days. </p>
<h3>Booking Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735244132_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$1448.0</td>
<td>$1423.1</td>
<td>$1434.9</td>
<td>$4000.00</td>
<td>$573.9K</td>
<td align="right">63</td>
<td align="right">4</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1430.4</td>
<td>$1410.4</td>
<td>$1430.4</td>
<td>$4000.00</td>
<td>$143.0K</td>
<td align="right">63</td>
<td align="right">5</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$510.3</td>
<td>$500.0</td>
<td>$500.0</td>
<td>$6500.00</td>
<td>$100.0K</td>
<td align="right">5</td>
<td align="right">2</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/31/25</td>
<td>$915.0</td>
<td>$895.0</td>
<td>$904.69</td>
<td>$4250.00</td>
<td>$90.4K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$716.1</td>
<td>$702.4</td>
<td>$716.1</td>
<td>$5100.00</td>
<td>$71.6K</td>
<td align="right">16</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Booking Holdings</h3>
<p>Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.</p>
<p>In light of the recent options history for Booking Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Booking Holdings Standing Right Now?</h3>
<ul>
<li>With a trading volume of 24,501, the price of BKNG is down by -0.19%, reaching $5113.08.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 56 days from now.</li>
</ul>
<h3>What The Experts Say On Booking Holdings</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $5774.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JMP Securities has decided to maintain their Market Outperform rating on Booking Holdings, which currently sits at a price target of $6100.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Booking Holdings, targeting a price of $6000.<br />
&#x2A; An analyst from B of A Securities persists with their Neutral rating on Booking Holdings, maintaining a target price of $5522.<br />
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $5400.<br />
&#x2A; In a cautious move, an analyst from Baird downgraded its rating to Outperform, setting a price target of $5850. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Booking Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


BKNG

Smart Money Is Betting Big In BKNG Options

<p>Financial giants have made a conspicuous bullish move on General Motors. Our analysis of options history for General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $354,833, and 8 were calls, valued at $252,002.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $65.0 for General Motors over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for General Motors's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across General Motors's significant trades, within a strike price range of $25.0 to $65.0, over the past month.</p>
<h3>General Motors Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735244127_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.05</td>
<td>$11.95</td>
<td>$12.05</td>
<td>$65.00</td>
<td>$322.9K</td>
<td>129</td>
<td align="right">269</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.2</td>
<td>$12.05</td>
<td>$12.2</td>
<td>$47.00</td>
<td>$37.8K</td>
<td>1.0K</td>
<td align="right">31</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$6.95</td>
<td>$6.85</td>
<td>$6.9</td>
<td>$49.00</td>
<td>$34.5K</td>
<td>2.3K</td>
<td align="right">142</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.95</td>
<td>$6.9</td>
<td>$6.94</td>
<td>$49.00</td>
<td>$33.9K</td>
<td>2.3K</td>
<td align="right">281</td>
</tr>
<tr>
<td>GM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.68</td>
<td>$1.68</td>
<td>$1.68</td>
<td>$50.00</td>
<td>$31.9K</td>
<td>3.3K</td>
<td align="right">309</td>
</tr>
</tbody>
</table>
</p>
<h3>About General Motors</h3>
<p>General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its us market share leader crown in 2022, after losing it to Toyota due to the chip shortage in 2021. 2023's share was 16.5%. GM's Cruise autonomous vehicle arm has previously done driverless geofenced AV robotaxi services in San Francisco and other cities but after a 2023 accident GM decided in December 2024 that it will focus on AVs in personal vehicles. GM should own 100% of Cruise by 2025. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.</p>
<p>After a thorough review of the options trading surrounding General Motors, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is General Motors Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,279,564, the price of GM is up by 1.35%, reaching $54.23.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 33 days from now.</li>
</ul>
<h3>What Analysts Are Saying About General Motors</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $50.333333333333336.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wells Fargo persists with their Underweight rating on General Motors, maintaining a target price of $35.<br />
&#x2A; An analyst from Morgan Stanley has elevated its stance to Equal-Weight, setting a new price target at $54.<br />
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on General Motors, which currently sits at a price target of $62. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest General Motors options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Spotlight on General Motors: Analyzing the Surge in Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Affirm Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AFRM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Affirm Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 46%, bearish.</p>
<p>Out of all of the special options we uncovered, 6 are puts, for a total amount of $736,660, and 9 are calls, for a total amount of $527,916.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $85.0 for Affirm Holdings over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Affirm Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Affirm Holdings's substantial trades, within a strike price spectrum from $30.0 to $85.0 over the preceding 30 days.</p>
<h3>Affirm Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735244122_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$12.95</td>
<td>$12.85</td>
<td>$12.85</td>
<td>$72.50</td>
<td>$257.0K</td>
<td align="right">89</td>
<td align="right">201</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.5</td>
<td>$4.45</td>
<td>$4.45</td>
<td>$67.50</td>
<td>$165.0K</td>
<td align="right">460</td>
<td align="right">734</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$23.7</td>
<td>$23.45</td>
<td>$23.45</td>
<td>$67.50</td>
<td>$147.7K</td>
<td align="right">87</td>
<td align="right">63</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.15</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$68.00</td>
<td>$107.8K</td>
<td align="right">35</td>
<td align="right">590</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.45</td>
<td>$4.4</td>
<td>$4.4</td>
<td>$67.50</td>
<td>$89.3K</td>
<td align="right">460</td>
<td align="right">246</td>
</tr>
</tbody>
</table>
</p>
<h3>About Affirm Holdings</h3>
<p>Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.</p>
<p>In light of the recent options history for Affirm Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Affirm Holdings</h3>
<ul>
<li>Trading volume stands at 1,961,133, with AFRM's price up by 1.97%, positioned at $67.19.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 42 days.</li>
</ul>
<h3>Professional Analyst Ratings for Affirm Holdings</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $77.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a positive move, an analyst from JMP Securities has upgraded their rating to Market Outperform and adjusted the price target to $78.<br />
&#x2A; Consistent in their evaluation, an analyst from Deutsche Bank keeps a Hold rating on Affirm Holdings with a target price of $75.<br />
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Affirm Holdings with a target price of $74.<br />
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Affirm Holdings, maintaining a target price of $78.<br />
&#x2A; An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $82. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Affirm Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


AFRM

A Closer Look at Affirm Holdings's Options Market Dynamics

<p><a href="https://asia.nikkei.com/Business/Business-deals/Honda-Nissan-talks-on-merger-ratio-may-start-at-5-to-1-Nikkei-analysis" title="https://asia.nikkei.com/Business/Business-deals/Honda-Nissan-talks-on-merger-ratio-may-start-at-5-to-1-Nikkei-analysis">https://asia.nikkei.com/Business/Business-deals/Honda-Nissan-talks-on-merger-ratio-may-start-at-5-to-1-Nikkei-analysis</a></p>


NSANY

'Honda-Nissan talks on merger ratio may start at 5-to-1: Nikkei analysis' - Nikkei

<p>Deep-pocketed investors have adopted a bullish approach towards BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BBAI usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 32 extraordinary options activities for BigBear.ai Hldgs. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 46% leaning bullish and 46% bearish. Among these notable options, 3 are puts, totaling $75,075, and 29 are calls, amounting to $2,330,271.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1.0 to $7.0 for BigBear.ai Hldgs over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for BigBear.ai Hldgs's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of BigBear.ai Hldgs's whale activity within a strike price range from $1.0 to $7.0 in the last 30 days. </p>
<h3>BigBear.ai Hldgs Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735243232_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$2.4</td>
<td>$2.3</td>
<td>$2.3</td>
<td>$3.50</td>
<td>$219.6K</td>
<td>9.6K</td>
<td>6.6K</td>
</tr>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.9</td>
<td>$2.6</td>
<td>$2.9</td>
<td>$2.00</td>
<td>$209.6K</td>
<td>1.6K</td>
<td>2.7K</td>
</tr>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$2.8</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$3.50</td>
<td>$141.0K</td>
<td>9.6K</td>
<td>8.3K</td>
</tr>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$2.85</td>
<td>$2.8</td>
<td>$2.8</td>
<td>$2.00</td>
<td>$140.0K</td>
<td>1.6K</td>
<td>836</td>
</tr>
<tr>
<td>BBAI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$2.55</td>
<td>$2.4</td>
<td>$2.4</td>
<td>$3.50</td>
<td>$131.0K</td>
<td>9.6K</td>
<td>633</td>
</tr>
</tbody>
</table>
</p>
<h3>About BigBear.ai Hldgs</h3>
<p>BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains &amp; logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber &amp; Engineering segment and Analytics segment.</p>
<p>Following our analysis of the options activities associated with BigBear.ai Hldgs, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of BigBear.ai Hldgs</h3>
<ul>
<li>Trading volume stands at 93,999,331, with BBAI's price up by 21.59%, positioned at $4.54.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 70 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest BigBear.ai Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


BBAI

BigBear.ai Hldgs Unusual Options Activity

<p>High-rolling investors have positioned themselves bullish on SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SOFI often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 38 options trades for SoFi Techs. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 50% bullish and 39% bearish. Among all the options we identified, there was one put, amounting to $40,332, and 37 calls, totaling $2,193,077.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.0 to $30.0 for SoFi Techs during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for SoFi Techs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoFi Techs's whale trades within a strike price range from $7.0 to $30.0 in the last 30 days. </p>
<h3>SoFi Techs Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735243227_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$3.7</td>
<td>$3.6</td>
<td>$3.67</td>
<td>$16.00</td>
<td>$213.1K</td>
<td>5.5K</td>
<td>643</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.0</td>
<td>$1.98</td>
<td>$2.01</td>
<td>$17.00</td>
<td>$200.9K</td>
<td>10.4K</td>
<td>1.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.45</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$20.00</td>
<td>$159.0K</td>
<td>14.0K</td>
<td>1.5K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.97</td>
<td>$2.9</td>
<td>$2.9</td>
<td>$15.00</td>
<td>$145.8K</td>
<td>13.1K</td>
<td>503</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.1</td>
<td>$3.7</td>
<td>$4.05</td>
<td>$12.00</td>
<td>$111.7K</td>
<td>30.6K</td>
<td>0</td>
</tr>
</tbody>
</table>
</p>
<h3>About SoFi Techs</h3>
<p>SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.</p>
<p>Having examined the options trading patterns of SoFi Techs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of SoFi Techs</h3>
<ul>
<li>Trading volume stands at 26,370,003, with SOFI's price up by 3.87%, positioned at $16.64.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 32 days.</li>
</ul>
<h3>Expert Opinions on SoFi Techs</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $13.666666666666666.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from B of A Securities downgraded its rating to Underperform, setting a price target of $12.<br />
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on SoFi Techs, which currently sits at a price target of $16.<br />
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Underweight rating for SoFi Techs, targeting a price of $13. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest SoFi Techs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


SOFI

Behind the Scenes of SoFi Techs's Latest Options Trends

<p>Financial giants have made a conspicuous bullish move on DraftKings. Our analysis of options history for DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) revealed 17 unusual trades.</p>
<p>Delving into the details, we found 70% of traders were bullish, while 17% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $533,320, and 9 were calls, valued at $479,040.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $55.0 for DraftKings over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for DraftKings's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of DraftKings's whale activity within a strike price range from $35.0 to $55.0 in the last 30 days. </p>
<h3>DraftKings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735243222_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.25</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$39.00</td>
<td>$293.4K</td>
<td>674</td>
<td align="right">65</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$7.2</td>
<td>$7.1</td>
<td>$7.2</td>
<td>$40.00</td>
<td>$75.6K</td>
<td>439</td>
<td align="right">115</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.97</td>
<td>$2.85</td>
<td>$2.97</td>
<td>$55.00</td>
<td>$59.4K</td>
<td>22.8K</td>
<td align="right">1</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.96</td>
<td>$2.85</td>
<td>$2.96</td>
<td>$55.00</td>
<td>$59.3K</td>
<td>22.8K</td>
<td align="right">401</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.96</td>
<td>$2.86</td>
<td>$2.96</td>
<td>$55.00</td>
<td>$59.2K</td>
<td>22.8K</td>
<td align="right">811</td>
</tr>
</tbody>
</table>
</p>
<h3>About DraftKings</h3>
<p>DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 30 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.</p>
<p>Having examined the options trading patterns of DraftKings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is DraftKings Standing Right Now?</h3>
<ul>
<li>With a volume of 3,279,598, the price of DKNG is down -0.13% at $38.52. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 49 days.</li>
</ul>
<h3>What The Experts Say On DraftKings</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $53.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on DraftKings, which currently sits at a price target of $53. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DraftKings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


DKNG

DraftKings Options Trading: A Deep Dive into Market Sentiment

<p>Canaccord Genuity  analyst Joseph Vafi   maintains Payfare (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PAY#TSX">PAY</a>) with a Hold and raises the price target from C$2 to C$4.</p>


Price Target

Analyst Ratings

TSX:PAY

Canaccord Genuity Maintains Hold on Payfare, Raises Price Target to C$4

<p>After suffering a recent earnings miss combined with a challenging economic backdrop, shares of recreational vehicle provider <strong>Winnebago Industries, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) have printed gobs of red ink over the trailing month. Nevertheless, historical data reveals that investors tend to view bouts of unusual volatility as a buying opportunity, thus making the case for bullish speculation.</p>
<p>First, one of the main contributors to the downside in WGO stock centers on the underlying company's fiscal-first-quarter results. Winnebago <a href="https://www.benzinga.com/news/earnings/24/12/42615254/winnebago-industries-stock-falls-after-q1-earnings-miss-amid-challenging-marine-operating-environment">reported an adjusted loss per share of 3 cents</a>, badly missing analysts' consensus view of 20 cents. Further, revenue slipped 18% on a year-over-year basis to $625.6 million, also missing the estimated target of $672.232 million.</p>
<p>Second, management provided additional context, but this failed to bolster investor confidence. "As expected, the RV and marine operating environment remained challenging in the first quarter, marked by subdued consumer demand and a cautious dealer network reluctant to make significant commitments on new orders ahead of the historically slow winter season," said President and CEO <strong>Michael Happe</strong>.</p>
<p>Nevertheless, the head executive stated that the company anticipates a rise in demand as the RV and marine markets enter the more sales-friendly spring season. To be fair, <a href="https://www.benzinga.com/24/12/42654183/is-winnebago-industries-steering-towards-a-turnaround-in-h2-analysts-are-split">analyst views on a turnaround for WGO stock are split</a>. However, a fundamental argument for upside speculation does exist.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/24/12/42689806/netflix-to-release-beyonce-bowl-nfl-halftime-performance-as-standalone-special">Netflix To Release &#8216;Beyoncé Bowl&#8217; NFL Halftime Performance As Standalone Special</a></strong></p>
<h2 class="wp-block-heading">Historical Trends Favor WGO Stock as a Value Play</h2>
<p>Under normal market circumstances, Winnebago stock tends to carry a neutral trajectory. Specifically, over the trailing five years, the odds that on any given Friday, WGO would generate a positive return relative to Monday's opening price comes in at 50.2%. This figure is calculated by dividing the number of positive weeks over the total number of weeks in the dataset (i.e. last five years).</p>
<p>However, this baseline metric doesn't reveal the emotional shifts in sentiment that may occur during periods of unusual volatility. In other words, pricing events that extend multiple standard deviations below the mean could impact the fear-greed continuum much more greatly than normal market sessions. Therefore, data-driven investors may be better served with a Bayesian inference to calculate <em>conditional</em> probabilities.</p>
<p>Last week, WGO stock lost 9.49% of its market value, which is a rare occurrence. In the past five years, there have only been 14 instances (not including last week) where WGO lost 9.49% or worse. Interestingly, eight of the following weeks saw a positive return or a success ratio of 57.14%.</p>
<p>Additional context makes Winnebago even more enticing. Four of the weekly losses totaling 9.49% or worse occurred in February and March of 2020. Presumably, most investors agree that COVID-19 represents a unique market impact that's unlikely to materialize again anytime soon.</p>
<p>Taking out the impact of COVID-19, the success ratio improves to 70%, with 10 weeks seeing a loss of 9.49% or worse and seven of the following weeks resulting in a positive return.</p>
<h2 class="wp-block-heading">A Bull Call Spread Beckons</h2>
<p>Considering investors&#8217; tendency to buy the dip in WGO stock, speculators may want to consider <a href="https://www.benzinga.com/money/bull-spread#:~:text=A%20bull%20call%20spread%20involves,expires%20on%20the%20same%20date.">bull call spreads</a> of Winnebago shares. This options strategy involves buying a call and simultaneously selling a call, both for the same expiration date. The idea is to take the credit from the short call to partially offset the debit paid for the long call, thus discounting the long position.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="374" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain-1024x374.jpg" alt="" class="wp-image-708024" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain-1024x374.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain-300x110.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain-768x281.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain-1536x562.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26135830/WGO-stock-options-chain.jpg 1578w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>For WGO stock, the next available options chain expires on Jan. 17, 2025. Given the skepticism surrounding Winnebago's business and comeback intentions, market makers are currently providing attractive pricing for bull call spreads.</p>
<p>For example, the Jan. 17 47.50/50.00 bull call spread — buy the $47.50 call, simultaneously sell the $50 call — carries a net debit of $125 after applying the options multiplier. Should WGO stock hit or exceed the short call strike price of $50, the payout is the difference between the strike prices minus the net debit paid or $125.</p>
<p>In other words, within a few weeks, bullish speculators have the opportunity to pocket a 100% payout. That's an enticing proposition, given that, statistically, investors tend to load the boat when WGO stock encounters unusually steep volatility.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42688941/are-us-vehicles-under-30000-a-thing-of-the-past-trumps-mexico-tariff-plans-could-change-auto-market"><strong>Are Sub-$30,000 Cars Disappearing? Trump&#8217;s Tariff Plans Could Reshape US Auto Market</strong></a></li>
</ul>
<p><em>Photo: Jonathan Weiss/Shutterstock.com</em></p>


Earnings Misses

Long Ideas

Options Corner: Winnebago's Implosion Could Signal A Comeback Opportunity

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Neumora Therapeutics</strong>.</p>
<p>Looking at options history for Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) we detected 12 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $581,375 and 6, calls, for a total amount of $245,900.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $15.0 for Neumora Therapeutics over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Neumora Therapeutics options trades today is 7461.43 with a total volume of 6,284.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Neumora Therapeutics's big money trades within a strike price range of $5.0 to $15.0 over the last 30 days.</p>
<h3>Neumora Therapeutics Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735242345_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NMRA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.35</td>
<td>$1.15</td>
<td>$1.45</td>
<td>$5.00</td>
<td>$378.0K</td>
<td>15.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>NMRA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.0</td>
<td>$3.7</td>
<td>$3.79</td>
<td>$12.50</td>
<td>$77.4K</td>
<td>7.6K</td>
<td>246</td>
</tr>
<tr>
<td>NMRA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$5.7</td>
<td>$5.0</td>
<td>$5.5</td>
<td>$10.00</td>
<td>$55.0K</td>
<td>8</td>
<td>100</td>
</tr>
<tr>
<td>NMRA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.4</td>
<td>$2.25</td>
<td>$2.25</td>
<td>$7.50</td>
<td>$44.4K</td>
<td>8.2K</td>
<td>211</td>
</tr>
<tr>
<td>NMRA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.3</td>
<td>$3.9</td>
<td>$4.0</td>
<td>$12.50</td>
<td>$40.0K</td>
<td>7.6K</td>
<td>414</td>
</tr>
</tbody>
</table>
</p>
<h3>About Neumora Therapeutics</h3>
<p>Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.</p>
<p>In light of the recent options history for Neumora Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Neumora Therapeutics's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 422,366, the NMRA's price is up by 1.03%, now at $10.74. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 70 days.</li>
</ul>
<h3>What The Experts Say On Neumora Therapeutics</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $30.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $30.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Neumora Therapeutics with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


NMRA

This Is What Whales Are Betting On Neumora Therapeutics

<p>Financial giants have made a conspicuous bullish move on e.l.f. Beauty. Our analysis of options history for e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) revealed 9 unusual trades.</p>
<p>Delving into the details, we found 33% of traders were bullish, while 22% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $697,100, and 6 were calls, valued at $298,944.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $115.0 to $200.0 for e.l.f. Beauty during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of e.l.f. Beauty stands at 123.67, with a total volume reaching 796.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in e.l.f. Beauty, situated within the strike price corridor from $115.0 to $200.0, throughout the last 30 days.</p>
<h3>e.l.f. Beauty Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735242340_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$18.9</td>
<td>$18.5</td>
<td>$18.6</td>
<td>$130.00</td>
<td>$558.0K</td>
<td align="right">174</td>
<td align="right">300</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.7</td>
<td>$6.6</td>
<td>$6.7</td>
<td>$132.00</td>
<td>$81.0K</td>
<td align="right">1</td>
<td align="right">145</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$69.8</td>
<td>$68.3</td>
<td>$69.8</td>
<td>$200.00</td>
<td>$69.8K</td>
<td align="right">40</td>
<td align="right">0</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$70.1</td>
<td>$68.6</td>
<td>$69.3</td>
<td>$200.00</td>
<td>$69.3K</td>
<td align="right">40</td>
<td align="right">20</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$26.5</td>
<td>$26.2</td>
<td>$26.5</td>
<td>$140.00</td>
<td>$55.7K</td>
<td align="right">82</td>
<td align="right">42</td>
</tr>
</tbody>
</table>
</p>
<h3>About e.l.f. Beauty</h3>
<p>e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.</p>
<p>Following our analysis of the options activities associated with e.l.f. Beauty, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is e.l.f. Beauty Standing Right Now?</h3>
<ul>
<li>With a trading volume of 353,827, the price of ELF is down by -0.16%, reaching $131.7.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 40 days from now.</li>
</ul>
<h3>What Analysts Are Saying About e.l.f. Beauty</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $165.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from DA Davidson persists with their Buy rating on e.l.f. Beauty, maintaining a target price of $170.<br />
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $150.<br />
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $170.<br />
&#x2A; An analyst from DA Davidson persists with their Buy rating on e.l.f. Beauty, maintaining a target price of $170.<br />
&#x2A; In a cautious move, an analyst from Goldman Sachs downgraded its rating to Buy, setting a price target of $165. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest e.l.f. Beauty options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


e.l.f. Beauty Unusual Options Activity For December 26

<p>Deep-pocketed investors have adopted a bearish approach towards Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LRCX usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 20 extraordinary options activities for Lam Research. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 30% leaning bullish and 40% bearish. Among these notable options, 12 are puts, totaling $585,068, and 8 are calls, amounting to $1,196,232.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $54.0 to $164.0 for Lam Research over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Lam Research stands at 793.58, with a total volume reaching 4,701.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lam Research, situated within the strike price corridor from $54.0 to $164.0, throughout the last 30 days.</p>
<h3>Lam Research Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735242335_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.45</td>
<td>$5.15</td>
<td>$5.25</td>
<td>$85.00</td>
<td>$787.5K</td>
<td align="right">627</td>
<td>1.5K</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$8.85</td>
<td>$8.75</td>
<td>$8.85</td>
<td>$68.00</td>
<td>$172.5K</td>
<td align="right">72</td>
<td>0</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/03/25</td>
<td>$10.95</td>
<td>$10.75</td>
<td>$10.84</td>
<td>$85.00</td>
<td>$54.2K</td>
<td align="right">0</td>
<td>350</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$93.7</td>
<td>$89.65</td>
<td>$90.05</td>
<td>$164.00</td>
<td>$54.0K</td>
<td align="right">0</td>
<td>6</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/03/25</td>
<td>$11.15</td>
<td>$10.4</td>
<td>$10.8</td>
<td>$85.00</td>
<td>$54.0K</td>
<td align="right">0</td>
<td>200</td>
</tr>
</tbody>
</table>
</p>
<h3>About Lam Research</h3>
<p>Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.</p>
<h3>Lam Research's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,523,239, the price of LRCX is up by 0.7%, reaching $74.35.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 27 days from now.</li>
</ul>
<h3>What The Experts Say On Lam Research</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $82.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Lam Research, maintaining a target price of $83.<br />
&#x2A; An analyst from Bernstein has decided to maintain their Market Perform rating on Lam Research, which currently sits at a price target of $85.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Lam Research with a target price of $78. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lam Research options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


LRCX

Smart Money Is Betting Big In LRCX Options

Insider Trades

SKYH

Sky Harbour Group: Rozek Alexander Buffett (Director) Buys 152,486 @ Avg Price: $9.50

Pieris Pharmaceuticals OKs 1-for-80 reverse stock split

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Pieris Pharmaceuticals</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pirs-stock-quote/"><strong>PIRS</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Pieris Pharmaceuticals reported earnings per share of -$3.95.</li><li>The company reported revenue of $53,000.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/pirs-stock-earnings-pieris-pharmaceuticals-for-q1-of-2024/">PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024

The latest announcement is out from Pieris Pharmaceuticals (PIRS). Pieris Pharmaceuticals, Inc. has received a notice from Les Laboratoires Servier...

Pieris Pharmaceuticals Faces Agreement Termination and Pursues New Opportunities

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>It&rsquo;s time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news to start the day with!</p>



<p>Moving stocks this morning a partnerships, a public offering, clinical trial news and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Dermata Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/"><strong>DRMA</strong></a>) stock is rocketing more than 123% alongside heavy pre-market trading.</li>



<li><strong>Nuzee </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/"><strong>NUZE</strong></a>) shares are soaring over 75% with strong early morning trading.</li>



<li><strong>Hoth Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/hoth-stock-quote/"><strong>HOTH</strong></a>) stock is surging more than 45% <a href="https://www.nasdaq.com/press-release/hoth-therapeutics-partners-lts-therapy-systems-accelerate-novel-alzheimers-treatment">on a new partnership</a> to develop its Alzheimer&rsquo;s treatment.</li>



<li><strong>Allarity Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/"><strong>ALLR</strong></a>) shares are increasing over 44% after encouraging investors to <a href="https://finance.yahoo.com/news/allarity-encourages-shareholders-vote-reverse-100000785.html">vote for a reverse stock split</a>.</li>



<li><strong>Regencell Bioscience</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/"><strong>RGC</strong></a>) stock is heading more than 33% higher alongside strong pre-market trading.</li>



<li><strong>Pieris Pharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/pirs-stock-quote/"><strong>PIRS</strong></a>) shares are rising over 28% after <a href="https://www.nasdaq.com/press-release/palvella-therapeutics-and-pieris-pharmaceuticals-announce-definitive-merger-agreement">announcing a merger agreement</a>.</li>



<li><strong>Bone Biologics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/"><strong>BBLG</strong></a>) stock is jumping more than 23% with heavy early morning trading today.</li>



<li><strong>NewGenIvf</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nivf-stock-quote/"><strong>NIVF</strong></a>) shares are climbing over 22% after providing a <a href="https://www.nasdaq.com/press-release/newgenivf-provides-update-potential-reverse-merger-covirix-2024-07-23">reverse merger update</a>.</li>



<li><strong>Perfect Moment</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pmnt-stock-quote/"><strong>PMNT</strong></a>) stock is getting a close to 19% boost after announcing a <a href="https://www.nasdaq.com/press-release/perfect-moment-teams-quiet-platforms-establish-distribution-center-us-2024-07-22">distribution center agreement</a>.</li>



<li><strong>Catheter Precision</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vtak-stock-quote/"><strong>VTAK</strong></a>) shares are up more than 16% without any clear news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>Azitra</strong>&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/aztr-stock-quote/"><strong>AZTR</strong></a>) stock is crashing over 73% but only <a href="https://investorplace.com/2024/07/why-is-azitra-aztr-stock-up-315-today/">after a massive rally yesterday</a>.</li>



<li><strong>Conn&rsquo;s </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/"><strong>CONN</strong></a>) shares are plummeting 28% on <a href="https://www.12newsnow.com/article/news/local/texas/conns-reportedly-planning-mass-closures/502-4db60564-6fdd-4ffa-ae26-899bec91f75c">reports of impending store closures</a>.</li>



<li><strong>ATI Physical Therapy</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/atip-stock-quote/"><strong>ATIP</strong></a>) stock is diving more than 25% without any obvious news this morning.</li>



<li><strong>Verastem </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/vstm-stock-quote/"><strong>VSTM</strong></a>) shares are tumbling over 25% on a <a href="https://finance.yahoo.com/news/verastem-oncology-announces-proposed-public-200500583.html">proposed public offering</a>.</li>



<li><strong>Agape ATP</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/atpc-stock-quote/"><strong>ATPC</strong></a>) stock is taking an almost 24% beating after a rally yesterday.</li>



<li><strong>AtlasClear </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/atch-stock-quote/"><strong>ATCH</strong></a>) shares are sliding more than 22% despite a lack of news on Wednesday.</li>



<li><strong>Sage Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sage-stock-quote/"><strong>SAGE</strong></a>) stock is dropping over 22% after reporting <a href="https://www.nasdaq.com/press-release/sage-therapeutics-and-biogen-announce-topline-results-phase-2-kinetic-2-study-sage">Phase 2 topline results</a>.</li>



<li><strong>Volato </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/"><strong>SOAR</strong></a>) shares are decreasing more than 21% <a href="https://www.nasdaq.com/press-release/volato-updates-fractional-program-additional-differentiated-benefits-2024-07-23">after a recent rally</a>.</li>



<li><strong>Chijet Motor</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/"><strong>CJET</strong></a>) stock is slipping over 19% following yesterday&rsquo;s rally.</li>



<li><strong>Salarius Pharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/"><strong>SLRX</strong></a>) shares close out our pre-market stock movers down more than 19% after a rally yesterday.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pieris Pharma surges on all-stock merger deal

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Allarity Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/"><strong>ALLR</strong></a>) stock is on the rise Wednesday as the clinical-stage biopharmaceutical company is encouraging its shareholders to vote in favor of a <a href="https://finance.yahoo.com/news/allarity-encourages-shareholders-vote-reverse-100000785.html">reverse stock split</a>.</p>



<p>Allarity Therapeutics put out a press release pushing for investors to approve the reverse stock split during an upcoming shareholder meeting. That meeting is set to take place on Friday.</p>



<p>Allarity Therapeutics is also advising its investors to approve the reduction of its authorized shares alongside the reverse stock split. It says that investors who have previously voted against these matters should reconsider their decision.</p>



<p>Here&rsquo;s a porition of what the company said to investors in the news release.</p>




<p>&ldquo;Failure to secure approval for the reverse stock split may hinder management&rsquo;s ability to execute its strategy, to the potential detriment of stockholders. Additionally, it may impede business development initiatives dependent on the issuance of common stock. It is essential to understand that a reverse stock split consolidates existing shares, preserving the Company&rsquo;s overall value and each shareholder&rsquo;s respective ownership percentage.&rdquo;</p>




<h2>What&rsquo;s Behind the ALLR Reverse Stock Split?</h2>



<p>Allarity Therapeutics is pushing for this reverse stock split to avoid the delisting of its shares. The company&rsquo;s stock is trading well below the $1 minimum bid price required to remain on the <strong>Nasdaq Exchange</strong>.</p>



<p>ALLR stock is up 4.6% as of Wednesday afternoon. That comes with 59 million shares traded as compared to a daily average of about 7 million shares.</p>



<p>Investors will want to keep reading for more of the most recent stock market stories!</p>



<p>We have all of the hottest stock market news investors need to know about on Wednesday! A few examples include what&rsquo;s happening with shares of <strong>General Motors</strong>&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/gm-stock-quote/"><strong>GM</strong></a>) and <strong>Pieris Pharmaceuticals</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/pirs-stock-quote/"><strong>PIRS</strong></a>) stock, as well as other stock market stories for today! You can find out all about these topics at the links below!</p>



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/general-motors-is-backing-down-on-electric-vehicles-whats-going-on/">General Motors Is Backing Down on Electric Vehicles. What&rsquo;s Going On?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-pieris-pharmaceuticals-pirs-stock-up-77-today/">Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-are-stocks-down-today-69/">Why Are Stocks Down Today?</a></li>
</ul><p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/2024/07/allr-stock-alert-allarity-therapeutics-pushes-shareholders-to-back-reverse-split/">ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Pieris Pharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/pirs-stock-quote/"><strong>PIRS</strong></a>) stock is rocketing higher on Wednesday after <a href="https://finance.yahoo.com/news/palvella-therapeutics-pieris-pharmaceuticals-announce-103000148.html">announcing a merger agreement</a> with <strong>Palvella Therapeutics</strong>.</p>



<p>Pieris Pharmaceuticals and Palvella Therapeutics will enact an all-stock transfer for this merger. That will result in Pieris Pharmaceuticals issuing shares of PIRS stock to Palvella stockholders. This will cancel out those investors shares of capital stock of Palvella.</p>



<p>Pieris Pharmaceuticals notes that after the merger, 18% of the combined company will belong to pre-merger PIRS shareholders. The remaining 82% will belong to current investors in Palvella.</p>



<p>Palvella founder and CEO Wes Kaupinen said the following about the merger.</p>




<p>&ldquo;The expected proceeds from the merger and concurrent private financing are expected to fund us through multiple clinical trial milestones, including generating results from the single-arm, baseline-controlled Phase 3 clinical trial of QTORIN&trade; rapamycin for the treatment of microcystic lymphatic malformations, a serious, rare and chronically debilitating genetic disease for which there are currently no FDA-approved therapies.&rdquo;</p>




<h2>What This Means for PIRS Stock</h2>



<p>When this merger closes, Palvella Therapeutics will be the surviving company. This will see its board of directors made up of four current Palvella members and one member from Pieris Pharmaceuticals. The deal is set to close in Q4 2024.</p>



<p>PIRS stock is up 77.3% as of Wednesday morning with 5 million shares traded. Its daily average trading volume is only about 20,000 shares.</p>



<p>Investors will want to keep reading for more of the most recent stock market stories!</p>



<p>We have all of the hottest stock market news that investors need to know about on Wednesday. A few examples include what&rsquo;s happening with stocks today and more of the latest news. All of that info is ready at the links below!</p>



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-are-stocks-down-today-69/">Why Are Stocks Down Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-hoth-therapeutics-hoth-stock-moving-today/">Why Is Hoth Therapeutics (HOTH) Stock Moving Today?</a></li>



<li><a href="https://investorplace.com/2024/07/rivn-stock-alert-rivian-must-face-lawsuit-over-alleged-tesla-trade-secret-theft/">RIVN Stock Alert: Rivian Must Face Lawsuit Over Alleged Tesla Trade Secret Theft</a></li>
</ul><p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/2024/07/why-is-pieris-pharmaceuticals-pirs-stock-up-77-today/">Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Pieris Pharmaceuticals</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pirs-stock-quote/"><strong>PIRS</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Pieris Pharmaceuticals reported earnings per share of -$2.76.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/pirs-stock-earnings-pieris-pharmaceuticals-for-q2-of-2024/">PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q2 2024

Pieris Pharmaceuticals ( ($PIRS) ) has shared an announcement. Pieris Pharmaceuticals announced the approval of several key proposals during a spec...

Pieris Pharmaceuticals Announces Merger and Share Increase

New option listings for December 16th include Pieris Pharmaceuticals (PVLA). Option delistings effective December 16th include Pieris Pharmaceutica...

One new option listing and one option delisting on December 16th

ATIP

HOTH

PMNT

SLRX

VTAK

Press Releases

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. - PIRS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, ENV, PIRS, BALY on Behalf of Shareholders

PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders

Health Care

Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations

Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference

Management

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations

PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, ACNB, PIRS, OBDE on Behalf of Shareholders

Comments

(PIRS) Forecast

(PIRS) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga